Dash Acquisitions Inc. Sells 69,954 Shares of Danaher Corporation $DHR

Dash Acquisitions Inc. reduced its holdings in Danaher Corporation (NYSE:DHRFree Report) by 86.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 11,231 shares of the conglomerate’s stock after selling 69,954 shares during the period. Dash Acquisitions Inc.’s holdings in Danaher were worth $2,404,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. White Pine Capital LLC boosted its position in Danaher by 1.4% during the second quarter. White Pine Capital LLC now owns 3,494 shares of the conglomerate’s stock worth $690,000 after purchasing an additional 49 shares during the period. SOL Capital Management CO grew its position in Danaher by 2.8% during the third quarter. SOL Capital Management CO now owns 1,829 shares of the conglomerate’s stock worth $363,000 after buying an additional 50 shares in the last quarter. Boyd Watterson Asset Management LLC OH increased its position in shares of Danaher by 2.1% in the second quarter. Boyd Watterson Asset Management LLC OH now owns 2,524 shares of the conglomerate’s stock worth $499,000 after purchasing an additional 51 shares during the period. Worth Financial Advisory Group LLC raised its position in shares of Danaher by 4.6% in the 2nd quarter. Worth Financial Advisory Group LLC now owns 1,195 shares of the conglomerate’s stock valued at $236,000 after buying an additional 53 shares in the last quarter. Finally, Howard Capital Management Group LLC lifted its stake in Danaher by 4.8% during the third quarter. Howard Capital Management Group LLC now owns 1,159 shares of the conglomerate’s stock worth $230,000 after purchasing an additional 53 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on DHR shares. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Danaher in a research note on Monday, December 29th. Morgan Stanley began coverage on Danaher in a research note on Monday, December 1st. They issued an “overweight” rating and a $270.00 price objective on the stock. Leerink Partners increased their target price on shares of Danaher from $260.00 to $270.00 and gave the stock an “outperform” rating in a research note on Friday, January 16th. Guggenheim boosted their price objective on Danaher from $250.00 to $275.00 and gave the company a “buy” rating in a report on Friday, January 2nd. Finally, HSBC raised their price target on shares of Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a research report on Monday, December 1st. Twenty analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $252.09.

Read Our Latest Research Report on Danaher

Danaher Stock Performance

Danaher stock opened at $234.91 on Friday. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $258.23. The firm has a market capitalization of $165.93 billion, a PE ratio of 48.43, a price-to-earnings-growth ratio of 3.65 and a beta of 0.89. The firm’s 50 day simple moving average is $230.26 and its 200 day simple moving average is $213.09.

Danaher (NYSE:DHRGet Free Report) last released its earnings results on Monday, October 20th. The conglomerate reported $1.89 EPS for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The business had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $6 billion. During the same quarter in the prior year, the firm earned $1.71 earnings per share. The firm’s revenue was up 4.4% on a year-over-year basis. As a group, analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date is Friday, December 26th. Danaher’s dividend payout ratio (DPR) is currently 26.39%.

Insider Buying and Selling

In other news, SVP Brian W. Ellis sold 21,776 shares of the business’s stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the sale, the senior vice president owned 14,553 shares in the company, valued at approximately $3,190,454.19. The trade was a 59.94% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Teri List sold 3,298 shares of the business’s stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total transaction of $746,997.00. Following the sale, the director directly owned 20,762 shares in the company, valued at $4,702,593. The trade was a 13.71% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 30,248 shares of company stock valued at $6,609,663 over the last three months. Corporate insiders own 11.10% of the company’s stock.

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Articles

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.